RBMXL3

gene
On this page

Also known as FLJ40249

Summary

RBMXL3 (RBMX like 3, HGNC:26859) is a protein-coding gene on chromosome Xq23, encoding RNA-binding motif protein, X-linked-like-3 (Q8N7X1). RNA-binding protein involved in glucocorticoid regulation of pulmonary surfactant protein B (SFTPB) mRNA stability.

Predicted to enable mRNA binding activity and snRNA binding activity. Predicted to be involved in mRNA splicing, via spliceosome.

Source: NCBI Gene 139804 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 5 total
  • MANE Select transcript: NM_001145346

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26859
Approved symbolRBMXL3
NameRBMX like 3
LocationXq23
Locus typegene with protein product
StatusApproved
AliasesFLJ40249
Ensembl geneENSG00000175718
Ensembl biotypeprotein_coding
OMIM301136
Entrez139804

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000424776

RefSeq mRNA: 1 — MANE Select: NM_001145346 NM_001145346

CCDS: CCDS55478

Canonical transcript exons

ENST00000424776 — 1 exons

ExonStartEnd
ENSE00001785091115189410115192868

Expression profiles

Bgee: expression breadth tissue_specific, 6 present calls, max score 73.36.

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047373.36silver quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099172.58gold quality
right testisUBERON:000453458.31gold quality
testisUBERON:000047356.61gold quality
left testisUBERON:000453356.03gold quality
colonic epitheliumUBERON:000039741.25gold quality
bone marrow cellCL:000209238.01gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
skeletal muscle tissueUBERON:000113436.04gold quality
ganglionic eminenceUBERON:000402335.49gold quality
sural nerveUBERON:001548835.15gold quality
tonsilUBERON:000237234.31gold quality
muscle tissueUBERON:000238533.01gold quality
bone marrowUBERON:000237132.69gold quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
urinary bladderUBERON:000125531.00gold quality
liverUBERON:000210730.49gold quality
adrenal tissueUBERON:001830330.41gold quality
descending thoracic aortaUBERON:000234529.88gold quality
stromal cell of endometriumCL:000225529.87gold quality
prefrontal cortexUBERON:000045129.66gold quality
lymph nodeUBERON:000002928.74gold quality
monocyteCL:000057628.63gold quality
leukocyteCL:000073828.54gold quality
uterine cervixUBERON:000000228.38gold quality
calcaneal tendonUBERON:000370128.33gold quality
cortex of kidneyUBERON:000122528.29gold quality
duodenumUBERON:000211428.14gold quality
myometriumUBERON:000129628.06gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.15

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

27 targeting RBMXL3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-302C-5P99.9772.563642
HSA-MIR-590-3P99.9674.346478
HSA-MIR-552-5P99.9368.561583
HSA-MIR-5003-3P99.8569.292517
HSA-MIR-684499.8270.692423
HSA-MIR-548AG99.7769.251492
HSA-MIR-7856-5P99.7569.992901
HSA-MIR-442299.7272.072908
HSA-MIR-494-3P99.7071.452795
HSA-MIR-548M99.7068.871749
HSA-MIR-548AI99.6969.241494
HSA-MIR-548BA99.6969.141514
HSA-MIR-570-5P99.6969.241494
HSA-MIR-3136-3P99.5766.59781
HSA-MIR-7155-3P99.5766.48794
HSA-MIR-392399.5269.21446
HSA-MIR-653-5P99.4667.351300
HSA-MIR-4735-5P99.4368.491780
HSA-MIR-670-3P99.0368.882404
HSA-MIR-477398.3567.301710
HSA-MIR-376C-3P97.6368.881263
HSA-MIR-6773-5P97.0464.30595
HSA-MIR-3189-3P96.8066.34896
HSA-MIR-6724-5P96.4163.11507
HSA-MIR-468395.2965.98631
HSA-MIR-55495.2066.98341
HSA-MIR-1229-5P94.5765.78487

Literature-anchored findings (GeneRIF, showing 1)

  • A primate-specific RNA-binding protein (RBMXL3) is involved in glucocorticoid regulation of human pulmonary surfactant protein B (SP-B) mRNA stability. (PMID:33719563)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusRbmxl2ENSMUSG00000073894
rattus_norvegicusRbmxl2ENSRNOG00000090098

Paralogs (36): DAZAP1 (ENSG00000071626), CIRBP (ENSG00000099622), RBM23 (ENSG00000100461), RBM3 (ENSG00000102317), NCL (ENSG00000115053), TIA1 (ENSG00000116001), HNRNPA2B1 (ENSG00000122566), RBM19 (ENSG00000122965), RBM39 (ENSG00000131051), MSI1 (ENSG00000135097), HNRNPA1 (ENSG00000135486), HNRNPD (ENSG00000138668), HNRNPA1L2 (ENSG00000139675), RBMX (ENSG00000147274), A1CF (ENSG00000148584), TIAL1 (ENSG00000151923), RBM46 (ENSG00000151962), HNRNPDL (ENSG00000152795), MSI2 (ENSG00000153944), RBM47 (ENSG00000163694), RBMY1F (ENSG00000169800), HNRNPA3 (ENSG00000170144), RBMXL2 (ENSG00000170748), RBM4B (ENSG00000173914), RBM4 (ENSG00000173933), HNRNPA0 (ENSG00000177733), TRNAU1AP (ENSG00000180098), HNRNPAB (ENSG00000197451), RBMXL1 (ENSG00000213516), HNRNPA1L3 (ENSG00000224578), RBMY1J (ENSG00000226941), RBMY1A1 (ENSG00000234414), RBMY1E (ENSG00000242389), RBMY1B (ENSG00000242875), RBMY1D (ENSG00000244395), DND1 (ENSG00000256453)

Protein

Protein identifiers

RNA-binding motif protein, X-linked-like-3Q8N7X1 (reviewed: Q8N7X1)

All UniProt accessions (1): Q8N7X1

UniProt curated annotations — full annotation on UniProt →

Function. RNA-binding protein involved in glucocorticoid regulation of pulmonary surfactant protein B (SFTPB) mRNA stability.

RefSeq proteins (1): NP_001138818* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000504RRM_domDomain
IPR012677Nucleotide-bd_a/b_plait_sfHomologous_superfamily
IPR035979RBD_domain_sfHomologous_superfamily
IPR050441RBMFamily

Pfam: PF00076

UniProt features (30 total): compositionally biased region 15, sequence conflict 9, region of interest 4, chain 1, domain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8N7X1-F140.870.02

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 18 (showing top): GOBP_RNA_SPLICING, GOMF_MRNA_BINDING, GOMF_SNRNA_BINDING, chrXq23, GOBP_MRNA_PROCESSING, MAFG_TARGET_GENES, MIR4422, MIR548BA, MIR548AI_MIR570_5P, MIR548AG, MIR4683, MIR6773_5P, MIR1229_5P, MIR6724_5P, GOBP_MRNA_METABOLIC_PROCESS

GO Biological Process (1): mRNA splicing, via spliceosome (GO:0000398)

GO Molecular Function (4): RNA binding (GO:0003723), mRNA binding (GO:0003729), snRNA binding (GO:0017069), nucleic acid binding (GO:0003676)

GO Cellular Component (1): organelle (GO:0043226)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
RNA binding2
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile1
mRNA processing1
nucleic acid binding1
binding1
cellular anatomical structure1

Protein interactions and networks

STRING

1514 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RBMXL3HNRNPCP07910497
RBMXL3KHDRBS1Q07666414
RBMXL3TEKTL1Q8IYK2383
RBMXL3LRRIQ4A6NIV6362
RBMXL3YTHDC2Q9H6S0355
RBMXL3FRG1Q14331355
RBMXL3WTAPQ15007344
RBMXL3YTHDC1Q96MU7344
RBMXL3METTL16Q86W50337
RBMXL3ALKBH1Q13686325
RBMXL3ETV3LQ6ZN32316
RBMXL3MAGEB16A2A368311
RBMXL3ALKBH5Q6P6C2309
RBMXL3YTHDF1Q9BYJ9307
RBMXL3METTL14Q9HCE5304

IntAct

4 interactions, top by confidence:

ABTypeScore
NHNRNPDLpsi-mi:“MI:0914”(association)0.530
Mpsi-mi:“MI:0914”(association)0.350
KRASIGKV2D-29psi-mi:“MI:0914”(association)0.350

BioGRID (14): RBMXL3 (Affinity Capture-MS), RBMXL3 (Proximity Label-MS), RBMXL3 (Affinity Capture-MS), RBMXL3 (Affinity Capture-MS), RBMXL3 (Affinity Capture-MS), RBMXL3 (Affinity Capture-MS), RBMXL3 (Affinity Capture-MS), RBMXL3 (Affinity Capture-MS), RBMXL3 (Affinity Capture-MS), RBMXL3 (Affinity Capture-MS), RBMXL3 (Affinity Capture-MS), RBMXL3 (Affinity Capture-MS), RBMXL3 (Protein-RNA), RBMXL3 (Affinity Capture-MS)

ESM2 similar proteins: A0A0J9YWL9, A0A0J9YY54, A0A0U1RQI7, A0A494C071, A6NNC1, A6QL64, B3KS81, D3YZV8, E2RYF7, E9Q6E9, F1LWT0, F8W0I5, O60732, P0C8Z4, P0DKJ7, P0DKJ8, P0DKL2, P0DPF3, P18751, P20930, P43537, P53353, P59797, P62521, Q01456, Q08AG5, Q12816, Q3BBV2, Q5H9R4, Q5HY64, Q5JPF3, Q6P902, Q6ZQX7, Q86T75, Q86VE3, Q86VQ3, Q8BGJ3, Q8N307, Q8N7U7, Q8N7X1

Diamond homologs: A0A0A0LLY1, A0A0D1C8Z4, A5A6M3, C0HFE5, D3Z4I3, D4AE41, M0R7T6, O22703, O35698, O75526, O89086, O93235, P04147, P0C8Z4, P10979, P19682, P19683, P19684, P28644, P38159, P39697, P48809, P49310, P49311, P49313, P49314, P60824, P60825, P60826, P84586, P98179, Q03250, Q03251, Q03878, Q04836, Q05966, Q08473, Q08935, Q08937, Q14011

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

5 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign3
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

131 predictions. Top by Δscore:

VariantEffectΔscore
X:115189413:T:TAdonor_gain0.9800
X:115190449:G:Adonor_gain0.9000
X:115189486:CA:Cdonor_gain0.8900
X:115189487:AA:Adonor_gain0.8900
X:115189485:TCA:Tdonor_gain0.8300
X:115189654:C:Tdonor_gain0.8000
X:115190146:AGG:Adonor_gain0.7300
X:115190146:AGGC:Adonor_gain0.7200
X:115189491:TCAAA:Tdonor_gain0.7000
X:115190456:G:Adonor_gain0.6800
X:115189422:C:Tdonor_gain0.6200
X:115189584:C:CAacceptor_gain0.6000
X:115190254:C:CTdonor_gain0.5700
X:115190255:T:TTdonor_gain0.5700
X:115189427:A:Tdonor_gain0.5600
X:115189423:C:Tdonor_gain0.5500
X:115189419:G:Tdonor_gain0.5200
X:115189426:CA:Cdonor_gain0.5100
X:115190527:G:Adonor_gain0.5100
X:115189554:T:TAdonor_gain0.5000
X:115192867:T:Cdonor_gain0.5000
X:115190146:AGGCC:Adonor_gain0.4800
X:115189851:TCG:Tdonor_gain0.4700
X:115189488:A:Cdonor_gain0.4600
X:115189414:C:Adonor_gain0.4500
X:115190200:C:Adonor_gain0.4400
X:115190342:C:CTdonor_gain0.4400
X:115189957:CAG:Cdonor_gain0.4200
X:115189656:A:ACdonor_gain0.4100
X:115189419:G:GTdonor_gain0.3900

AlphaMissense

6954 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
X:115189592:T:CF51L0.998
X:115189594:C:AF51L0.998
X:115189594:C:GF51L0.998
X:115189602:T:AV54D0.998
X:115189607:T:CF56L0.998
X:115189609:C:AF56L0.998
X:115189609:C:GF56L0.998
X:115189608:T:CF56S0.997
X:115189598:T:CF53L0.996
X:115189600:C:AF53L0.996
X:115189600:C:GF53L0.996
X:115189472:T:CF11L0.995
X:115189474:C:AF11L0.995
X:115189474:C:GF11L0.995
X:115189523:T:CF28L0.995
X:115189525:T:AF28L0.995
X:115189525:T:GF28L0.995
X:115189593:T:CF51S0.995
X:115189473:T:CF11S0.994
X:115189524:T:CF28S0.994
X:115189635:C:AA65D0.993
X:115189512:T:AL24H0.992
X:115189596:C:AA52E0.992
X:115189599:T:CF53S0.991
X:115189608:T:GF56C0.991
X:115189470:T:CL10P0.990
X:115189476:T:AI12N0.989
X:115189512:T:CL24P0.989
X:115189485:T:CL15P0.988
X:115189634:G:CA65P0.988

dbSNP variants (sampled 300 via entrez): RS1000843178 (X:115189944 C>G,T), RS1002469427 (X:115190100 G>A), RS1002926891 (X:115191727 G>A,C,T), RS1005511741 (X:115191115 C>T), RS1005667785 (X:115193157 A>T), RS1005694529 (X:115189194 G>C), RS1005719965 (X:115192689 A>G), RS1007143175 (X:115189909 C>A,G), RS1007583913 (X:115189826 G>C), RS1009145759 (X:115190598 A>C,G), RS1010569231 (X:115192256 C>A,T), RS1010621570 (X:115192094 C>T), RS1011884863 (X:115189403 A>G,T), RS1012325921 (X:115189148 T>A), RS1013300424 (X:115187444 C>A)

Disease associations

OMIM: gene MIM:301136 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

7 total (human), top 7 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, increases expression, increases methylation2
Aflatoxin B1decreases expression, decreases methylation2
FR900359increases phosphorylation1
2-palmitoylglycerolincreases expression1
Acetaminophendecreases expression1
Diethylhexyl Phthalatedecreases expression1
Valproic Acidincreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.